Streetbeat News

Earnings

BCRX

BioCryst Pharma (NASDAQ:BCRX) is scheduled to release its quarterly earnings report on 2024-02-26, with analysts expecting an EPS of $-0.24. The company's past earnings performance shows a history of beating EPS estimates, which has positively impacted its share price. However, shares have declined 36.66% over the last 52 weeks, indicating a bearish outlook among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:01 pm

GILT

Gilat Satellite Networks (NASDAQ:GILT) is expected to report an EPS of $0.07 in its upcoming quarterly earnings on 2024-02-26. Historically, GILT has shown a mixed reaction to earnings reports, with share price movements ranging from a 1.5% increase to a 2.0% decrease the day after earnings announcements. Shares are currently trading at $6.32, reflecting an 8.22% increase over the last 52 weeks. Investors are advised to watch for the company's performance against the EPS estimate and any forward-looking guidance provided.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:01 pm

CGBD

Carlyle Secured Lending (NASDAQ:CGBD) is scheduled to release its quarterly earnings report on February 26, 2024, with an estimated EPS of $0.52. The company's past earnings performance shows a mixed impact on its stock price, with minor fluctuations following earnings announcements. Shares are currently trading at $15.43, reflecting a slight 0.45% decrease over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:01 pm

OPAD

Offerpad Solutions (NYSE:OPAD) is scheduled to release its quarterly earnings report on Monday, 2024-02-26, with an expected EPS of $-0.47. Analysts and investors are keen on not just the earnings beat or miss but also the company's guidance for future growth. Offerpad's past earnings performance shows a pattern of not meeting EPS estimates, leading to subsequent drops in share price. Currently, shares are trading at $8.83, marking a 3.25% increase over the last 52 weeks, indicating a generally positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:01 pm

SOI

Solaris Oilfield Infra (NYSE:SOI) is scheduled to release its quarterly earnings report on 2024-02-26, with analysts expecting an EPS of $0.14. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss leading to a 6.77% drop. Shares are currently trading at $7.72, down 13.53% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:01 pm

ASUR

Asure Software (NASDAQ:ASUR) is scheduled to release its quarterly earnings report on 2024-02-26, with analysts expecting an EPS of $0.05. The company's past earnings performance shows a mix of beats and misses, with significant price changes following the announcements. Shares are currently trading at $9.99, down 11.46% over the last 52 weeks. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:01 pm

FRPT

Freshpet (NASDAQ:FRPT) is scheduled to release its quarterly earnings report on Monday, 2024-02-26, with an estimated EPS of $0.05. Analysts and investors will be closely watching for not only an earnings beat but also positive guidance for the next quarter. Historical data shows mixed reactions to past earnings reports, with the stock price experiencing minor fluctuations. Shares of Freshpet have seen a 49.33% increase over the last 52 weeks, indicating a generally positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:00 pm

ZM

Zoom Video Comms (NASDAQ:ZM) is scheduled to release its quarterly earnings report on Monday, with analysts estimating an EPS of $1.15. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat resulting in a slight drop. Shares are currently trading at $62.12, down 14.32% over the last year, indicating bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:00 pm

PODD

Insulet (NASDAQ:PODD) has received mixed analyst ratings over the last three months, with a shift towards more bullish perspectives in the last 30 days. The average 12-month price target for Insulet has been raised to $227.0, indicating a 17.25% increase from the previous target. Analysts from firms like Piper Sandler, JP Morgan, Stifel, Baird, and Morgan Stanley have adjusted their ratings and price targets, reflecting their evolving views on Insulet's market performance. Insulet's financial indicators such as revenue growth, net margin, ROE, ROA, and debt management are highlighted, showcasing the company's strong financial health and performance.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 7:00 pm

MODV

ModivCare Inc (NASDAQ:MODV) reported Q4 2023 revenue of $702.8 million, a 7.5% increase year-over-year, surpassing consensus estimates. Despite revenue growth, driven by an increase in non-emergency medical transportation trips and personal care services hours, the company's adjusted EPS fell to $1.29 from $2.11 a year ago, slightly above consensus. The decrease in membership due to Medicaid redetermination and margin pressure in the NEMT segment were noted as challenges. Deutsche Bank and Jefferies downgraded MODV, significantly lowering their price targets. ModivCare forecasts lower than expected revenues for Q1 2024 and the full year, contributing to a 40.6% drop in its stock price.

Portfolio Pulse from Vandana Singh

February 23, 2024 | 6:54 pm